Medicare Enrolled

Dr. Jerry Chandy, N.P.

Nurse Practitioner - Adult Health · Trenton, MI
Low-engagement
1675 KINGSWAY CT STE 1, Trenton, MI 48183
7346768530
In practice since 2013 (12 years)
NPI: 1023447695 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chandy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chandy

Dr. Jerry Chandy is a nurse practitioner - adult health in Trenton, MI, with 12 years of NPI registration.

Between the years covered by Open Payments, Dr. Chandy received a total of $9,458 from 48 pharmaceutical and/or device companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chandy is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice $9,458 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$9,458
Total received (2021-2024)
Avg $2,365/year across 4 years
Top 1% in MI for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
532
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,458 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,009
2023
$2,062
2022
$2,722
2021
$2,665

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$312
Lilly USA, LLC
$298
AstraZeneca Pharmaceuticals LP
$272
GlaxoSmithKline, LLC.
$203
ABBVIE INC.
$164
PFIZER INC.
$110
Exact Sciences Corporation
$90
Antares Pharma, Inc.
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Sumitomo Pharma America, Inc.
$65
Phathom Pharmaceuticals, Inc.
$60
Otsuka America Pharmaceutical, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$43
Mylan Specialty L.P.
$41
Phadia US Inc.
$31
Sage Therapeutics, Inc.
$27
Biogen, Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Tolmar, Inc.
$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Ardelyx, Inc.
$14
Top 3 companies account for 43.9% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,165
AstraZeneca Pharmaceuticals LP
$1,090
Lilly USA, LLC
$931
ABBVIE INC.
$855
GlaxoSmithKline, LLC.
$757
Janssen Pharmaceuticals, Inc
$524
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$327
Antares Pharma, Inc.
$323
AbbVie Inc.
$302
Teva Pharmaceuticals USA, Inc.
$286
Amgen Inc.
$251
PFIZER INC.
$229
Merck Sharp & Dohme LLC
$200
Novartis Pharmaceuticals Corporation
$153
Bayer HealthCare Pharmaceuticals Inc.
$153
SANOFI-AVENTIS U.S. LLC
$133
Amarin Pharma Inc.
$119
Exact Sciences Corporation
$118
IDORSIA PHARMACEUTICALS US INC
$116
Otsuka America Pharmaceutical, Inc.
$111
Sumitomo Pharma America, Inc.
$105
E.R. Squibb & Sons, L.L.C.
$103
Bayer Healthcare Pharmaceuticals Inc.
$102
Biohaven Pharmaceutical Holding Company Ltd.
$85
Abbott Laboratories
$83
Biohaven Pharmaceuticals, Inc.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Mylan Specialty L.P.
$66
Phathom Pharmaceuticals, Inc.
$60
ITI, Inc.
$59
Horizon Therapeutics plc
$55
UROVANT SCIENCES INC
$51
Phadia US Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$41
Supernus Pharmaceuticals, Inc.
$39
Axsome Therapeutics, Inc.
$35
DEXCOM, INC.
$29
Sage Therapeutics, Inc.
$27
CMP Pharma, Inc.
$23
Biogen, Inc.
$21
Lundbeck LLC
$20
Bausch Health US, LLC
$15
Boston Scientific Corporation
$15
Tolmar, Inc.
$14
Merck Sharp & Dohme Corporation
$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Ardelyx, Inc.
$14
Shield Therapeutics Inc
$14
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANORO ELLIPTA · AREXVY · AUSTEDO · Aimovig · AirDuo Digihaler · Auvelity · BAQSIMI · BASAGLAR · BREZTRI · CAPLYTA · CAROSPIR · COMIRNATY · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · ELIQUIS · EMGALITY · ENTRESTO · EVUSHELD · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GATTEX · GEMTESA · IBSRELA · ImmunoCAP · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · MOUNJARO · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREMARIN · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SKYCLARYS · SOLIQUA 100/33 · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VERQUVO · VOQUEZNA · VRAYLAR · Vascepa · WATCHMAN FLX · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XYOSTED · YUPELRI · Yupelri · ZEPBOUND · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - adult health in MI.

Looking for a nurse practitioner - adult health in Trenton?
Compare adult-health nurse practitioners in the Trenton area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners within 10 mi
198
Per 100K population
11.2
County median income
$59,521
Nearest hospital
COREWELL HEALTH TRENTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chandy is a nurse practitioner - adult health, with low-engagement industry engagement in the top 1% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Chandy receive payments from pharmaceutical companies?
Yes. Dr. Chandy received a total of $9,458 from 48 companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Chandy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →